T-cell therapies
| 3 min read
Pediatric brain cancer is extremely challenging to treat. Results from a Phase 1 cell therapy trial revealed encouraging long-term survival rates.
| 3 min read
Researchers showed that an oral medication can activate worn-out T cells.
| 4 min read
Living drugs are blurring the line between therapy and biology, challenging decades of assumptions about how medicines are made and controlled.
| 3 min read
MorphoSys licenses Hemibody technology from Cherry Biolabs in hopes of improving T cell-based therapeutics
Page 1 of 1 - 4 Total Items
